American consumers cannot purchase prescription drugs with the certainty that the products are safe and effective.

I really don't want to see us not resolve this problem.

As a doctor, such immorality of knowingly sentencing a patient to death by either denying them treatment or selling them an adulterated product, that is an absolutely chilling proposition.

We need your feedback so that we can help you keep up with the threat as it emerges.

I understand how this threat has changed, how the globalization of our economy has in fact affected your ability to do your work within our shores.

The market for prescription drugs has been the catalyst for a continuing series of frauds against American manufacturers and has provided cover for counterfeit drugs.

In just a little bit over a month's time, the Nation's physicians will face a 25 percent reduction in payment in the Medicare system. This severely affects access for Medicare patients and is something that could be resolved. Two weeks…

I would offer for those limited comparisons between ACA and the Medicare Modernization Act from 10 years ago.

I mean it is critical to our discussion.

And it seems to me it would be contrary to the policy you are proposing in the Part D proposed rule.

Not only has Part D come in at 45 percent under budget, the Congressional Budget Office has reduced its 10-year projections for Part D by over $100 billion for each of the last 3 years.

So in my mind, there is some confusion as to why, after 10 years, your agency felt that it must now reinterpret the noninterference clause.